Deltex Medical will be supporting a forthcoming congress in London on May 28th. Current Initiatives, Research and the Role of Hemodynamic Monitoring is free to attend for clinicians and healthcare providers…
FEDORA Study “Take-Homes” for clinicians
Clinician-led disseminator of medical news, TopMedTalk has reviewed the landmark FEDORA study into Goal-Directed Haemodynamic Therapy (GDHT). Reinforcing the conclusions from meta-analysis of 70 other studies, FEDORA supports the use…
TopMedTalk Journal Review of FEDORA study
The BJA recently published the FEDORA RCT of 420 patients. The study’s statistically significant results reinforce the UK’s NICE recommendation to use oesophageal Doppler monitor (ODM). Now, TopMedTalk, disseminator of…
Thought Leaders Target Adoption of Goal-Directed Haemodynamic Therapy
The University of Pennsylvania (UPenn) in conjunction with Evidence Based Perioperative Medicine (EBPOM) and UK Department for International Trade (DIT) has hosted the third annual “Quality Improvement Leadership Forum” with…
Support for ODM from Largest Ever Intra-Op Haemodynamic RCT
The British Journal of Anaesthesia (BJA) has published a new study, the largest ever positive Randomised Clinical Trial (RCT) on Goal-Directed Haemodynamic Therapy(GDHT) using Deltex Medical’s ODM system. The results demonstrate…
Severe Weather Warning: Planned Office Closure
The snow is coming to the south coast! We have a severe weather warning in place for later this week, so have taken the decision in advance to shut Deltex’s…
Deltex Wins Biggest Ever Hospital Contract
Haemodynamic monitoring specialist, Deltex Medical’s French distributor, Gamida has been awarded a new tender to supply hospitals in Paris with CardioQ-ODM+ equipment. Deltex’s long term partner has won an eight…
Suite of solutions delivers monitoring for all, says Deltex at EBPOM
Mid January saw Deltex supporting the EBPOM (Evidence-based perioperative medicine) organisation at its first meeting of 2018. Entitled “Current Initiatives, Research and the Role of Hemodynamic Monitoring” the event was…
Flagship hospital has only “followed the data”
A few weeks ago we reported that a major U.S. hospital is adopting Deltex’s ODM technology. The hospital had made a clinical decision based on its own evidence that haemodynamic…
Deltex Article in New Statesman
Deltex Medical Managing Director Andy Mears has authored a piece that appears in the New Statesman. In a special feature edition, entitled “Shaping Healthcare Through Medtech,” numerous contributors talk positively…
